Trademark: BIOMARIN 1101916
Word
BIOMARIN
Device Descrption:
STONES,STACKED FORM LTR I
ID
1101916
Trademark Type
Figurative
Status
Registered: Registered/protected
Application Date
06 March 2006
Registration Date
06 March 2006
Renewal Date
06 March 2026
Owner(s)
Service
Griffith Hack
Goods and Services:
Class 1:
Assays, screening kits, for scientific analysis; assays, screening kits for measurement of disease markers for scientific purposes
Assays, screening kits, for scientific analysis; assays, screening kits for measurement of disease markers for scientific purposes
Class 5:
Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceuticals for treatment of inflammation, infectious diseases and cardiovascular diseases; assays, screening kits, devices, and equipment for medical analysis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease makers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; fungal lytic enzymes for the treatment of fungal infections; pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders; proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions; biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions; assays, screening kits, devices and equipment for diagnosis of disorders and physiological processes
Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceuticals for treatment of inflammation, infectious diseases and cardiovascular diseases; assays, screening kits, devices, and equipment for medical analysis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease makers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; fungal lytic enzymes for the treatment of fungal infections; pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders; proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions; biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions; assays, screening kits, devices and equipment for diagnosis of disorders and physiological processes